(Q43155083)

14 November 2017

title

Dose proportionality of once-daily trazodone extended-release caplets under fasting conditions (English)

1 reference

14 November 2017

David Karhu

1

1 reference

14 November 2017

Gerhard Groenewoud

series ordinal

2

1 reference

14 November 2017

Maria A Potgieter

series ordinal

3

1 reference

14 November 2017

Diane R Mould

series ordinal

4

1 reference

14 November 2017

publication date

19 February 2010

1 reference

The Journal of Clinical Pharmacology

14 November 2017

published in

1 reference

14 November 2017

volume

50

1 reference

14 November 2017

issue

12

1 reference

14 November 2017

page(s)

1438-1449

1 reference

Trazodone. A review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders

14 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270009360979

Detection of novel reactive metabolites of trazodone: evidence for CYP2D6-mediated bioactivation of m-chlorophenylpiperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009360979

Confirmation of the neurophysiologically predicted therapeutic effects of trazodone on its target symptoms depression, anxiety and insomnia by postmarketing clinical studies with a controlled-release formulation in depressed outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009360979

Single dose pharmacokinetics of trazodone in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009360979

Human CYP2D6 and metabolism of m-chlorophenylpiperazine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009360979

Trazodone‐a new assay procedure and some pharmacokinetic parameters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009360979

Comparative bioavailability of trazodone formulations using stable isotope methodology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009360979

A brief review of antidepressant efficacy, effectiveness, indications, and usage for major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009360979

Confidence interval criteria for assessment of dose proportionality.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009360979

Exploratory assessment of dose proportionality: review of current approaches and proposal for a practical criterion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009360979

Divisability of diltiazem matrix sustained-release tablets

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270009360979

21 January 2018

Identifiers

DOI

10.1177/0091270009360979

1 reference

release_26qkllqmhfgptnakizraopvyfm

14 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/26qkllqmhfgptnakizraopvyfm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference